Rohstoff Lokalanästhetikum Serie Bupivacain Hcl für Schmerzmittel 14252-80-3
Abstrakt
FALL:14252-80-3
MF:C18H28N2O.ClH
MW:324.89
EINECS:241-917-8
Schmelzpunkt:249-2510C
Lagertemperatur. Kühlschrank
Risk Statements 26/27/28
Sicherheitshinweise 22-36/37/39-45
RIDADR UN 2811 6.1/PG 2
WGK Deutschland 3
RTECS TK6125000
Gefahrenklasse 6.1(b)
Beschreibung:
Bupivacaine hydrochloride injection, USP is available in sterile isotonic solution for injection via local infiltration, peripheral nerve block, and caudal and lumbar epidural blocks. Solution of Bupivacaine hydrochloride injection, USP may be autoclaved. Solution is clear and colorless.
Bupivacaine hydrochloride USP is 2-Piperidinecarboxamide, 1-butyl-N-(2, 6-dimethylphenyl)-, monohydrochloride, monohydrate, a white, geruchlos, crystalline powder that is freely soluble in 95 percent ethanol, in Wasser löslich, and slightly soluble in chloroform or acetone.
Anwendungen :
Bupivacaine is indicated for local infiltration, peripheral nerve block, sympathetic nerve block, and epidural and caudal blocks. It is sometimes used in combination with epinephrine to prevent systemic absorption and extend the duration of action. Das 0.75% (most concentrated) formulation is used in retrobulbar block.
Echtheitszertifikat
| Items Tested |
Spezifikation |
Ergebnis |
| Figuren |
A white, crystalline powder or colorless crystals. |
A white crystal. |
| Identifizierung |
IR should comply with the Reference Standard spectrum.
UV should comply with the Reference Standard spectrum.
An orange-red precipitate is performed. |
IR complies with the Reference standard spectrum.
UV complies with the Reference standard spectrum.
An orange-red precipitate is performed. |
| Melting range |
88 ~92 degree |
89.8-90.2Grad |
| Trocknungsverlust |
Nicht mehr als 1.0% |
0.22% |
| Readily carbonizable Substances |
The resolution has no more color than Matching Fluid A. |
Testgegenstände |
| Glührückstand |
Nicht mehr als 0.1% |
0.02% |
| Schwermetalle |
Nicht mehr als 0.001% |
Testgegenstände |
| Chloride |
Testgegenstände |
Testgegenstände |
| Assay (Testgegenstände) |
98.0%-102.0% |
99.96% |
| Ordinary Impurities |
≤1% |
Testgegenstände |
| Reaction |
Testgegenstände |
Testgegenstände |
| 1) Propitocainhydrochlorid |
FALL: 1786-81-8 |
| 2) Tetracainhydrochlorid |
FALL: 136-47-0 |
| 3) Procainhydrochlorid |
FALL: 51-05-8 |
| 4) Pramoxinhydrochlorid |
FALL: 637-58-1 |
| 5) Proparacainhydrochlorid |
FALL: 5875-06-9 |
| 6) Benzocainhydrochlorid |
FALL: 23239-88-5 |
| 7) Lidocainhydrochlorid |
FALL: 73-78-9 |
| 8) Articainhydrochlorid |
FALL: 23964-57-0 |
| 9) Levobupivacainhydrochlorid |
FALL: 27262-48-2 |
| 10) Ropivacainhydrochlorid |
FALL: 132112-35-7 |
| 11) Dibucainhydrochlorid |
FALL: 61-12-1 |
| 12) Bupivacainhydrochlorid |
FALL: 14252-80-3 |
| 13) Articaine |
FALL: 23964-58-1 |
| 14) Benzocain |
FALL: 94-09-7 |
| 15) Lidocain |
FALL: 137-58-6 |
| 16) Tetracain |
FALL: 94-24-6 |
| 17) PROCAINE |
FALL: 59-46-1 |
Verkaufsleiter